Copyright
©2007 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Dec 7, 2007; 13(45): 5985-5988
Published online Dec 7, 2007. doi: 10.3748/wjg.v13.i45.5985
Published online Dec 7, 2007. doi: 10.3748/wjg.v13.i45.5985
Updates on abdominal desmoid tumors
Bernardino Rampone, Corrado Pedrazzani, Daniele Marrelli, Enrico Pinto, Franco Roviello, Department of General Surgery and Surgical Oncology, Unit of Surgical Oncology, University of Siena, Italy
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Bernardino Rampone, Department of General Surgery and Surgical Oncology, Unit of Surgical Oncology, University of Siena, Policlinico Le Scotte, viale Bracci, 1, 53100, Siena, Italy. ramponebernardino@virgilio.it
Telephone: +39-5-77585156 Fax: +39-5-77233337
Received: May 17, 2007
Revised: June 16, 2007
Accepted: September 26, 2007
Published online: December 7, 2007
Revised: June 16, 2007
Accepted: September 26, 2007
Published online: December 7, 2007
Abstract
Desmoid tumor is a monoclonal, fibroblastic proliferation arising in musculoaponeurotic structures. This connective tissue hyperplasia infiltrates locally, recurs frequently after resection but does not metastasize. Abdominal desmoid occurs sporadically, in association with some familial syndromes and often represents a clinical dilemma for surgeons. The enigmatic biology and anatomical location of abdominal desmoids make treatment recommendations difficult. This distinct pathological entity is reviewed with a specific focus on aetiology and management.